Stocks / Pharmaceuticals
ARWRPharmaceuticals
Arrowhead Research Corporation
$67.751d +1.9%5d -18.1%settled close · 2026-09-17
Mkt cap $7.9B (3/25)β 1.5752w $29–90Shares 140.0MInd. Pharmaceutical PreparationsNasdaq since 1995Emp. 711HQ Pasadena, CAarrowheadpharma.com
Who’s talkingIdea Scout · free
Who’s talking about ARWR
No tracked investor commentary on ARWR yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 23 Nov 2026 after the close
Confirmed date · consensus EPS -1.67. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where ARWR’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 21 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-16 | ||||||
| 2026-09-15 | ||||||
| 2026-09-14 | ||||||
| 2026-08-28 | ||||||
| 2026-07-22 | ||||||
| 2026-07-17 | ||||||
| 2026-07-13 | ||||||
| 2026-07-10 | ||||||
| 2026-07-06 | ||||||
| 2026-06-24 | ||||||
| 2026-06-18 | ||||||
| 2026-06-17 | ||||||
| 2026-06-15 | ||||||
| 2026-04-24 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 | ||||||
| 2026-04-15 | ||||||
| 2026-04-09 | ||||||
| 2026-03-31 | ||||||
| 2026-03-25 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
ARWR is in this morning’s Brief.
Get The Brief — $20/mo →